Clinical Trial Update: Switching Study From Lamivudine to Clevudine in the Chronic Hepatitis B Patients [Phase 4]

View source ↗

Summary

This Phase 4 trial updates results of switching chronic hepatitis B patients from lamivudine to clevudine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Clevudine (clevudine)
• Lamivudine (lamivudine)

Snippet

Sponsor: Bukwang Pharmaceutical | Conditions: Chronic Hepatitis B | Phase 4 | Status: COMPLETED